EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Impact of cardiometabolic risk factors on hepatocellular carcinoma incidence in patients with chronic hepatitis B: A retrospective cohort study

Chanavee Toh, Kedsiree Sanit, Pimsiri Sripongpun, Naichaya Chamroonkul, Suthat Liangpunsakul, Teerha Piratvisuth, Apichat Kaewdech iD

PLOS One · 23.01.2026 · 21 (1) · e0341366

DOI: 10.1371/journal.pone.0341366 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift PLOS One, online erschienen am 23.01.2026. Verfasst von Chanavee Toh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Digital Innovation and Data Analytics, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hepatitis B, Chronic, Liver Neoplasms, Cardiometabolic Risk Factors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine, Prince of Songkla University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Chronic hepatitis B virus (HBV) infection remains a major global health burden and a leading cause of hepatocellular carcinoma (HCC). While cirrhosis is a well-established risk factor, the contributions of metabolic dysfunction-associated steatotic liver disease (MASLD) and cardiometabolic risk factors (CMRFs) are less clearly defined. This study aimed to evaluate the impact of MASLD and CMRFs on HCC risk in patients with chronic hepatitis B (CHB).

Methods

We conducted a retrospective cohort study of CHB patients at Songklanagarind Hospital between 2011 and 2021, excluding those diagnosed with HCC within six months of follow-up. Clinical and imaging data were analyzed. Cumulative HCC incidence was estimated using Nelson-Aalen plots. Multivariable Cox regression was used to identify independent predictors. The aMAP score was evaluated in subgroups with obesity, CMRFs, and MASLD.

Results

Among 4,944 patients, 151 (3.1%) developed HCC. Cirrhosis (adjusted hazard ratio [aHR] 7.22), obesity (aHR 1.85), and male sex (aHR 1.78) were independent risk factors. Statin use (aHR 0.43), higher platelet count (aHR 0.62), and higher albumin (aHR 0.64) were protective. Diabetes and hypertension showed nonsignificant trends, and steatosis and dyslipidemia without statins were not significantly associated with HCC. Risk increased with the number of CMRFs. The aMAP score showed good discrimination in patients with obesity (C-index 0.82), CMRFs (0.79), MASLD (0.74), and in the non-cirrhotic MASLD and non-MASLD (0.69 and 0.71, respectively).

Conclusions

Cirrhosis, male sex, and obesity were key HCC risk factors. The aMAP score effectively stratified HCC risk among metabolically at-risk CHB patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularHepatitis B, ChronicLiver NeoplasmsCardiometabolic Risk FactorsHumansMaleRetrospective StudiesFemaleIncidenceMiddle AgedAdultRisk FactorsObesityLiver Cirrhosis

Autor:innen und Institutionen

  • Division of Digital Innovation and Data Analytics, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
  • Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
  • Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
  • Roudebush Veterans' Administration Medical Center, Indianapolis, Indiana, United States of America.
  • NKC Institute of Gastroenterology and Hepatology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.

ORCID-Profile: Apichat Kaewdech

Förderung

  • Faculty of Medicine, Prince of Songkla University

Zitieren

APA

Toh, C., Sanit, K., Sripongpun, P., Chamroonkul, N., Liangpunsakul, S., Piratvisuth, T., & Kaewdech, A. (2026). Impact of cardiometabolic risk factors on hepatocellular carcinoma incidence in patients with chronic hepatitis B: A retrospective cohort study. PLOS One, 21(1), e0341366. https://doi.org/10.1371/journal.pone.0341366

Vancouver

Toh C, Sanit K, Sripongpun P, Chamroonkul N, Liangpunsakul S, Piratvisuth T, et al. Impact of cardiometabolic risk factors on hepatocellular carcinoma incidence in patients with chronic hepatitis B: A retrospective cohort study. PLOS One. 2026;21(1):e0341366. doi:10.1371/journal.pone.0341366

BibTeX
@article{Toh2026,
  author = {Toh, Chanavee and Sanit, Kedsiree and Sripongpun, Pimsiri and Chamroonkul, Naichaya and Liangpunsakul, Suthat and Piratvisuth, Teerha and Kaewdech, Apichat},
  title = {Impact of cardiometabolic risk factors on hepatocellular carcinoma incidence in patients with chronic hepatitis B: A retrospective cohort study},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {1},
  pages = {e0341366},
  doi = {10.1371/journal.pone.0341366}
}
Kostenlos starten →